查詢結果分析
來源資料
相關文獻
- Ferric Chloride Hexahydrate (Atofen®)與Iron Dextran (Desman®)使用於血液透析患者之臨床療效與安全性比較
- 降低血液透析病患紅血球生成素使用之改善專案
- The Clinical Experience of Higher rHuEPO Dosage in Chronic Hemodialysis Patients with Epo-Hyporesponsiveness
- Serum Transferrin Receptor is a Good Index of Erythropoietin Treatment in ESRD
- Assessment of Serum Erythropoietin Level in Chronic Hemodialysis Patients
- Intravenous Iron Dextran is Superior to Oral Ferrous Sulfate in the Correction of Anemia in Hemodialysis Patients
- Low Dose Intravenous Ascorbic ACID for Erythropoietin-Hyporesponsive Anemia in Hemodialysis Patients with Iron Overload
- 長期血液透析尿毒症病患接受低劑量紅血球生成素治療的血壓及生化值變化
- 血液透析之鐵劑輸注療法
- 血液透析病患貧血的處理
頁籤選單縮合
題名 | Ferric Chloride Hexahydrate (Atofen®)與Iron Dextran (Desman®)使用於血液透析患者之臨床療效與安全性比較=Compared the Efficacy and Safety of Ferric Chloride Hexahydrate (Atofen®) vs Iron Dextran (Desman®) in Hemodialysis Patients |
---|---|
作者 | 廖淑貞; 楊郁; 蔡玉娟; 康宜靜; 簡素玉; Liao, Shu-chen; Yan, Yu; Tsai, Yu-jang; Kang, I-ching; Chien, Su-yu; |
期刊 | 臺灣臨床藥學雜誌 |
出版日期 | 20050900 |
卷期 | 13:1 民94.09 |
頁次 | 頁17-28 |
分類號 | 418.23 |
語文 | chi |
關鍵詞 | 鐵劑; 貧血; 血液透析; 紅血球生成素; Iron supplementation; Ferric chloride hexahydrate; Iron dextran; Hemodialysis; Erythropoietin; rHuEPO; Anemia; |